Essential Oil with Anticancer Activity: An Overview

Author(s):  
Paola Angelini ◽  
Bruno Tirillini ◽  
Mohd Sayeed Akhtar ◽  
Luminita Dimitriu ◽  
Emma Bricchi ◽  
...  

Salvia judaica is an annual herb from genus Salvia L.; the largest genera of Lamiaceae. It’s a medicinal plant prominent in pharmaceutical applications in many countries around the world. This study aimed to explore bioactive compounds likely to be responsible for the plant anticancer activity, and evaluate anticancer effects, after determining the total content of phenols in the ethanol extract and essential oil in this species. Ethanol extract (EE) and essential oil (EO) were prepared from dried aerial parts (leaves and the flower). GC-MS analysis of EO showed the presence of/43/ effective compounds in varying proportions, the major compounds were sesquiterpenes like delta-cadinene, alpha-Gurjunene, beta-humulene, and alpha-caryophyllene. This is the first study revealed that S.judaica is so rich in phenols which proceeded S.officinalis, noting the superiority of the EE over the EO samples in the total phenols. Anticancer properties of EE and EO of S. judaica against MDA-231 breast cancer cell line were studied -for the first time - by cell cycle analysis and Annexin V/PI apoptosis assay using Flow cytometry technique. Cells were treated with EE (0.001, 0.01, 0.02, 0.1mg/ml) and EO (0.005, 0.01, 0.02, 0.03, 0.04 mg/ml) at various concentrations for48 h. The results revealed that both EE and EO induced cell cycle arrest at G1-phase. Cells treated with EE and EO for 48h showed increasing the percentage of cells in G1-phase and decreasing the percentage of cells in S-phase with increasing concentration compared with untreated cells (control). Annexin V-FITC/PI assay confirmed that EO and EE were able to induce apoptosis. Cells treated with EOat (0.04 mg/ml) for 48h resulted in apoptotic cells at 96.68%, and necrotic cells at 0.12%, compared with untreated cells. On the other hand, Cells treated with EE at (0.1 mg/ml) for 48h resulted in apoptotic cells at 94.43%, and necrotic cells at 0.47%, compared with control. Results revealed that EO is better than EE as anticancer; treatment with EO resulted in more apoptotic cells and less necrotic cells, and there were significant differences between them. This confirmed that EO contains specific anticancer compounds as showed by GC-MS analysis. However, more studies should be performed to explore antioxidants present in S.judaica and determine the underlying mechanism of their anti-breast cancer properties.


2006 ◽  
Vol 103 (1) ◽  
pp. 99-102 ◽  
Author(s):  
Muriel Sylvestre ◽  
André Pichette ◽  
Angélique Longtin ◽  
Francine Nagau ◽  
Jean Legault

Phytomedicine ◽  
2005 ◽  
Vol 12 (4) ◽  
pp. 299-304 ◽  
Author(s):  
M. Sylvestre ◽  
J. Legault ◽  
D. Dufour ◽  
A. Pichette

2020 ◽  
Vol 10 (4) ◽  
pp. 372-383
Author(s):  
Rajani Kurup ◽  
Ajikumaran Nair Sadasivan ◽  
Uthayakumari Kalavathy ◽  
Sabulal Baby

Background: Polyscias guilfoylei, commonly called ‘geranium aralia’, is an erect shrub with dark green leaves. P. guilfoylei has been introduced to tropical countries and is generally cultivated in gardens for ornamental purposes. There are no previous studies on the essential oil of P. guilfoylei and its biological activities. Objective: In this study, we report the chemical profile of P. guilfoylei leaf essential oil and its anticancer activity tested by various in vitro and in vivo assays. Methods: The chemical profile of P. guilfoylei leaf oil was elucidated by Gas Chromatographic analyses (GC-FID, GC-MS). Anticancer activity of P. guilfoylei leaf oil was tested by MTT, morphological observations, DNA ladder, comet, caspase, flow cytometry and in vivo assays. Results: Gas chromatographic profiling of P. guilfoylei leaf oil identified 50 constituents (β-selinene 49.59%, α-selinene 21.68%, (Z)-falcarinol 11.65%). In MTT assay, P. guilfoylei leaf oil at 50, 25, 10, 5 and 1 μg/ml showed 98.6 ± 1.2, 95.3 ± 0.78, 76.8 ± 1.59, 43.6 ± 0.99 and 39.8 ± 1.17% DLA cell death, respectively (CD50 5.96 μg/ml). In flow cytometry, the majority of P. guilfoylei leaf oil (25 μg/ml) treated DLA cells showed an accumulation/cell arrest in G2M phase (61.7 ± 2.6%). In P. guilfoylei leaf oil treated mice (40 days), 5 animals (83.3%, each) were protected in 25, 50 mg/kg groups. Conclusion: P. guilfoylei leaf oil, with minimal toxicity to normal cells, exhibited significant anticancer activity against lymphoma cells enhancing its potential as an anticancer agent.


2014 ◽  
Vol 6 (3) ◽  
pp. 191 ◽  
Author(s):  
Yumi ZuhanisHas-Yun Hashim ◽  
Abbas Phirdaous ◽  
Amid Azura

2007 ◽  
Vol 2 (12) ◽  
pp. 1934578X0700201 ◽  
Author(s):  
Muriel Sylvestre ◽  
André Pichette Angélique Longtin ◽  
Jean Legault

Leaf volatile components of Bursera simaruba (L.) Sarg., a native tree from tropical America used in traditional medicine, were extracted by hydrodistillation. The essential oil was analyzed by GC-MS. We have identified 38 compounds in this oil, of which limonene (46.7%), β-caryophyllene (14.7%), α-humulene (13.2%) and germacrene D (7.6%) are the major components. The anticancer activity of the essential oil was tested on human lung carcinoma cell line A-549 and human colon adenocarcinoma cell line, DLD-1. B. simaruba leaf essential oil was found to be active against both tumor cell lines, with a GI50 of 42 ± 2 μg/mL for A-549 and 48 ± 2 μg/mL for DLD-1. The evaluation of the cytotoxic properties of the major constituents of the oil indicates that α-humulene is possibly responsible for this activity.


Sign in / Sign up

Export Citation Format

Share Document